DK142676A - - Google Patents
Info
- Publication number
- DK142676A DK142676A DK142676A DK142676A DK142676A DK 142676 A DK142676 A DK 142676A DK 142676 A DK142676 A DK 142676A DK 142676 A DK142676 A DK 142676A DK 142676 A DK142676 A DK 142676A
- Authority
- DK
- Denmark
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7504075 | 1975-04-05 | ||
NLAANVRAGE7504075,A NL189199C (nl) | 1975-04-05 | 1975-04-05 | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
Publications (3)
Publication Number | Publication Date |
---|---|
DK142676A true DK142676A (sv) | 1976-10-06 |
DK142498B DK142498B (da) | 1980-11-10 |
DK142498C DK142498C (sv) | 1981-07-06 |
Family
ID=19823518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK142676AA DK142498B (da) | 1975-04-05 | 1976-03-30 | Analogifremgangsmåde til fremstilling af benzopyridoazepinderivater. |
Country Status (17)
Country | Link |
---|---|
US (1) | US4062848A (sv) |
JP (1) | JPS5942678B2 (sv) |
BE (1) | BE840362A (sv) |
CA (1) | CA1076571A (sv) |
CH (1) | CH622261A5 (sv) |
DE (1) | DE2614406A1 (sv) |
DK (1) | DK142498B (sv) |
ES (2) | ES446634A1 (sv) |
FI (1) | FI62087C (sv) |
FR (1) | FR2305986A1 (sv) |
GB (1) | GB1543171A (sv) |
HU (1) | HU179401B (sv) |
IE (1) | IE42969B1 (sv) |
LU (1) | LU74680A1 (sv) |
NL (2) | NL189199C (sv) |
SE (1) | SE422941B (sv) |
ZA (1) | ZA761756B (sv) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
JPS6336682A (ja) * | 1986-07-31 | 1988-02-17 | Matsushita Electric Ind Co Ltd | カセツト方式文字放送受信機 |
JPS63177670A (ja) * | 1987-01-31 | 1988-07-21 | Fujitsu General Ltd | 文字放送受信装置 |
JPS63215179A (ja) * | 1987-03-03 | 1988-09-07 | Fujitsu General Ltd | 受信装置 |
JPH055746Y2 (sv) * | 1988-04-27 | 1993-02-15 | ||
CA2026925A1 (en) * | 1989-10-05 | 1991-04-06 | Hiroshi Fukumi | Tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use |
EP0539164A1 (en) * | 1991-10-23 | 1993-04-28 | Sankyo Company Limited | Nitrogen-containing tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
WO1999051237A1 (en) * | 1998-04-02 | 1999-10-14 | Akzo Nobel N.V. | Oral liquid antidepressant solution |
YU74201A (sh) | 1999-04-19 | 2004-05-12 | Teva Pharmaceutical Industries Ltd. | Nova sinteza prstena piperazina |
AU781221B2 (en) * | 1999-04-19 | 2005-05-12 | Teva Pharmaceutical Industries Ltd. | Novel synthesis and crystallization of piperazine ring-containing compounds |
US6545149B2 (en) * | 1999-04-19 | 2003-04-08 | Teva Pharmaceutical Industries Ltd. | Synthesis and crystallization of piperazine ring-containing compounds |
CN1679586A (zh) * | 1999-04-19 | 2005-10-12 | 特瓦制药工业有限公司 | 含哌嗪环化合物的新型合成和结晶方法 |
US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
WO2001025185A1 (fr) * | 1999-09-30 | 2001-04-12 | Sumika Fine Chemicals Co., Ltd. | Procede de production de derive de piperazine |
WO2001038329A1 (fr) * | 1999-11-24 | 2001-05-31 | Sumika Fine Chemicals Co., Ltd. | Cristaux de mirtazapine anhydre et leur procede d'obtention |
WO2001042239A1 (fr) * | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Procede de preparation d'un compose pyridinemethanol |
CA2396066A1 (en) * | 2000-01-19 | 2001-07-26 | Akzo Nobel N.V. | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
CZ302368B6 (cs) | 2000-02-11 | 2011-04-13 | N.V. Organon | Farmaceutický prostredek |
IN190478B (sv) * | 2000-11-07 | 2003-08-02 | Sun Pharmaceutical Ind Ltd | |
US6660730B2 (en) * | 2000-11-27 | 2003-12-09 | Sumika Fine Chemicals Co., Ltd. | Anhydrous mirtazapine and process for preparing the same |
US20030105082A1 (en) * | 2001-12-03 | 2003-06-05 | Murphy Greer Marechal | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
US20040106124A1 (en) * | 2001-02-12 | 2004-06-03 | Murphy Greer M. | Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 and for improving the terapeutic response of humans having major depression and carrying the gene for apolipoprotein e4 |
US6399310B1 (en) | 2001-02-12 | 2002-06-04 | Akzo Nobel N.V. | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
EP1370549A4 (en) * | 2001-03-01 | 2005-03-09 | Teva Pharma | METHOD FOR PRODUCING MIRTAZAPINE INTERMEDIATE PRODUCTS |
US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
CZ296992B6 (cs) * | 2002-10-03 | 2006-08-16 | Zentiva, A.S. | Príprava a izolace 2-substituovaných-3-pyridylkarboxylových kyselin, jejich karboxylových solí a produktu redukce |
US20040192754A1 (en) * | 2003-03-24 | 2004-09-30 | Shapira Nathan Andrew | Methods for treating idiopathic hyperhidrosis and associated conditions |
UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
US7838029B1 (en) | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
MXPA06013163A (es) * | 2004-05-11 | 2007-02-13 | Pfizer Prod Inc | Combinacion de antipsicoticos atipicos y antagonistas del receptor 5-ht1b. |
EP1776160A1 (en) * | 2004-08-13 | 2007-04-25 | Omeros Corporation | Novel serotonin receptor ligands and their uses thereof |
WO2006023702A2 (en) * | 2004-08-20 | 2006-03-02 | Cypress Bioscience, Inc. | Method for treating sleep related breathing disorders with setiptiline |
US20080182987A1 (en) * | 2004-08-24 | 2008-07-31 | Sumitomo Chemical Company, Limited | Method For Producing 2-(4-Methyl-2-Phenylpiperazine-1-Yl)-3-Cyanopiridine |
JP4848704B2 (ja) * | 2004-08-24 | 2011-12-28 | 住友化学株式会社 | 2−(4−メチル−2−フェニルピペラジン−1−イル)−3−シアノピリジンの製造方法 |
TW200631584A (en) * | 2004-11-15 | 2006-09-16 | Akzo Nobel Nv | A medicament related to mirtazapine for the treatment of hot flush |
US20060122127A1 (en) * | 2004-11-17 | 2006-06-08 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtzapine treatment |
US20090306046A1 (en) * | 2005-06-27 | 2009-12-10 | N.V. Organon | Method of treatment of hormone depletion induced vasomotor symptoms |
CA2614289A1 (en) * | 2005-07-08 | 2007-01-18 | Braincells, Inc. | Methods for identifying agents and conditions that modulate neurogenesis |
CN1939918B (zh) * | 2005-09-30 | 2010-09-01 | 北京德众万全医药科技有限公司 | 一种米氮平的制备方法 |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
NZ568694A (en) | 2005-11-09 | 2011-09-30 | Zalicus Inc | Method, compositions, and kits for the treatment of medical conditions |
CN101304988A (zh) * | 2005-11-14 | 2008-11-12 | 住友化学株式会社 | 制备2-(4-甲基-2-苯基哌嗪-1-基)吡啶-3-甲醇的方法 |
EP1792618A1 (en) | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
WO2007101832A1 (en) * | 2006-03-06 | 2007-09-13 | N.V. Organon | An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
EP2026813A2 (en) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
US7858611B2 (en) * | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
US20070270413A1 (en) * | 2006-05-22 | 2007-11-22 | N.V. Organon | Mirtazapine for the treatment of neuropathic pain |
TW200815370A (en) * | 2006-06-16 | 2008-04-01 | Organon Nv | Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine |
AU2007292848A1 (en) * | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20080167363A1 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc | Modulation of Neurogenesis By Melatoninergic Agents |
US20080171750A1 (en) * | 2007-01-11 | 2008-07-17 | Braincells, Inc. | Modulation Of Neurogenesis With Use of Modafinil |
JP5192707B2 (ja) * | 2007-03-22 | 2013-05-08 | 住友化学株式会社 | ミルタザピンの製造方法 |
CA2684021A1 (en) | 2007-04-11 | 2008-10-23 | N.V. Organon | A method for the preparation of an enantiomer of a tetracyclic benzazepine |
EP2102203B1 (en) * | 2007-04-11 | 2016-02-17 | Merck Sharp & Dohme B.V. | A method for the preparation of an enantiomerically pure benzazepine |
US7994314B2 (en) * | 2007-04-11 | 2011-08-09 | N.V. Organon | Method for the preparation of an enantiomerically pure benzazepine |
US20080255348A1 (en) * | 2007-04-11 | 2008-10-16 | N.V. Organon | Method for the preparation of an enantiomer of a tetracyclic benzazepine |
EP2167096A4 (en) * | 2007-06-13 | 2010-07-14 | Cypress Bioscience Inc | IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM |
JP2009018992A (ja) * | 2007-07-10 | 2009-01-29 | Sumitomo Chemical Co Ltd | 光学活性ミルタザピンの製造方法 |
EP2288345B1 (en) | 2008-04-18 | 2015-06-10 | University College Dublin National University Of Ireland, Dublin | Psycho-pharmaceuticals |
US8461389B2 (en) | 2008-04-18 | 2013-06-11 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
WO2009156889A1 (en) * | 2008-06-25 | 2009-12-30 | Pfizer Inc. | Diaryl compounds and uses thereof |
US20110201804A1 (en) * | 2008-10-22 | 2011-08-18 | Watson Pharma Private Limited | Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN102432594B (zh) * | 2011-11-28 | 2013-09-11 | 山东鲁药制药有限公司 | 一种药物中间体1-(3-羟甲基吡啶-2-基)-2-苯基-4-甲基哌嗪的制备方法 |
CN103509020A (zh) * | 2013-10-21 | 2014-01-15 | 山东鲁药制药有限公司 | 一种米氮平的合成方法 |
CN104356133A (zh) * | 2014-11-25 | 2015-02-18 | 南京工业大学 | 一种制备抗抑郁药物米氮平的方法 |
JP6433809B2 (ja) * | 2015-02-20 | 2018-12-05 | 株式会社トクヤマ | 1−(3−ヒドロキシメチルピリジル−2−)−2−フェニル−4−メチルピペラジンの製造方法 |
KR102540021B1 (ko) | 2020-12-02 | 2023-06-07 | (주)유케이케미팜 | 대량 생산에 적합한 미르타자핀의 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL129434C (sv) * | 1966-03-12 | |||
NL7202963A (sv) * | 1972-03-07 | 1973-09-11 | ||
US3959470A (en) * | 1972-11-28 | 1976-05-25 | Mikhail Davidovich Mashkovsky | Psychotropic medicinal preparation |
-
1975
- 1975-04-05 NL NLAANVRAGE7504075,A patent/NL189199C/xx not_active IP Right Cessation
-
1976
- 1976-03-23 ZA ZA761756A patent/ZA761756B/xx unknown
- 1976-03-23 US US05/669,544 patent/US4062848A/en not_active Expired - Lifetime
- 1976-03-23 IE IE614/76A patent/IE42969B1/en unknown
- 1976-03-26 GB GB12270/76A patent/GB1543171A/en not_active Expired
- 1976-03-29 CH CH388676A patent/CH622261A5/de not_active IP Right Cessation
- 1976-03-30 DK DK142676AA patent/DK142498B/da active Protection Beyond IP Right Term
- 1976-04-01 FI FI760884A patent/FI62087C/fi not_active IP Right Cessation
- 1976-04-02 BE BE165832A patent/BE840362A/xx not_active IP Right Cessation
- 1976-04-02 LU LU74680A patent/LU74680A1/xx unknown
- 1976-04-02 DE DE19762614406 patent/DE2614406A1/de active Granted
- 1976-04-02 ES ES446634A patent/ES446634A1/es not_active Expired
- 1976-04-02 SE SE7603931A patent/SE422941B/sv active Protection Beyond IP Right Term
- 1976-04-02 JP JP51037678A patent/JPS5942678B2/ja not_active Expired
- 1976-04-02 FR FR7609686A patent/FR2305986A1/fr active Granted
- 1976-04-02 CA CA249,439A patent/CA1076571A/en not_active Expired
- 1976-04-05 HU HU76AO437A patent/HU179401B/hu unknown
-
1977
- 1977-05-31 ES ES459348A patent/ES459348A1/es not_active Expired
-
1994
- 1994-04-21 NL NL940007C patent/NL940007I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
NL7504075A (nl) | 1976-10-07 |
NL189199C (nl) | 1993-02-01 |
GB1543171A (en) | 1979-03-28 |
FI62087C (fi) | 1982-11-10 |
JPS51122099A (en) | 1976-10-25 |
AU1236176A (en) | 1977-09-29 |
LU74680A1 (sv) | 1976-11-11 |
NL940007I2 (nl) | 1994-10-17 |
DE2614406C2 (sv) | 1992-02-20 |
CH622261A5 (sv) | 1981-03-31 |
DE2614406A1 (de) | 1976-10-14 |
JPS5942678B2 (ja) | 1984-10-16 |
BE840362A (fr) | 1976-10-04 |
FI62087B (fi) | 1982-07-30 |
FI760884A (sv) | 1976-10-06 |
CA1076571A (en) | 1980-04-29 |
NL940007I1 (nl) | 1994-06-01 |
FR2305986A1 (fr) | 1976-10-29 |
US4062848A (en) | 1977-12-13 |
NL189199B (nl) | 1992-09-01 |
DK142498C (sv) | 1981-07-06 |
IE42969L (en) | 1976-10-05 |
ZA761756B (en) | 1977-03-30 |
IE42969B1 (en) | 1980-11-19 |
DK142498B (da) | 1980-11-10 |
HU179401B (en) | 1982-10-28 |
FR2305986B1 (sv) | 1980-06-13 |
ES446634A1 (es) | 1977-11-01 |
ES459348A1 (es) | 1978-03-16 |
SE422941B (sv) | 1982-04-05 |
SE7603931L (sv) | 1976-10-06 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed | ||
CTFF | Application for supplementary protection certificate (spc) filed |
Free format text: CA 1996 00007, 960311 |
|
PUP | Patent expired | ||
CTFG | Supplementary protection certificate (spc) issued |
Free format text: CA 1996 00007, 960311, EXPIRES: 20010330 |